Compound library / Longevity / Metabolic

SLU-PP-332

Synthetic small molecule (not a peptide) that activates ERR (estrogen-related receptor) transcription factors, studied in mice as an "exercise mimetic" for metabolic and endurance effects.

CategoryLongevity / Metabolic
Regulatory standingNo approved product cited
Typical routeOral
Half-lifeShort in rodent studies; human data essentially nonexistent
Common dose rangeNo established human dosing — animal-study compound only
Typical cycle lengthNot established

BioHack Track models SLU-PP-332 at a half-life of 2 hours, so every dose you log is decayed against that curve and the app shows estimated active levels — not just what you typed.

No approved product cited

No FDA-approved product for this compound is cited on this page, and no approved human dose is quoted. Treat the range below as research and community practice rather than a prescribed dose.

Reconstitution

Sold as research powder; not formulated for human use.

Storage

Store as directed by supplier.

Cautions

This is a research-chemical compound with essentially zero human safety data — it has not been tested in people. Grey-market sale for personal use carries unknown risk.

Track SLU-PP-332 in BioHack Track. Half-life, dose range and route come pre-filled from this library — log a dose and the app counts your vial down, models what is in your system, and puts it on the same chart as your labs and body composition.

Others in Longevity / Metabolic

Look up the research

These open a search of each database for SLU-PP-332 — they are not citations, and nothing here is evidence for any particular dose. The same links are in the app.

Work it out

Where these figures come from

The half-life, route and dose range on this page are compiled from published pharmacokinetic literature, manufacturer and product monographs where one exists, and the ranges commonly reported in clinical and research use. They are kept as a range rather than a single figure because that is what the sources actually support — a half-life varies with route, formulation and the person.

These are not citations, and this page is not a review of the evidence. Where a number matters to you, follow the database links above and read the source. We say so plainly rather than dressing a compiled reference up as one.

Nothing on this page has been reviewed by a named clinician. It is a reference for people already tracking a protocol, not a recommendation to start one.

Published by Creative Images LLC · Last updated · Corrections: support